Osteoarthritis • Organoids • Gene & Cell Therapy

Regenerating joints. Repairing tissue. Protecting the body from a toxic world.

We build human-relevant models of degenerative disease and apply exposure biology, stem cell systems, and translational gene/cell therapy. Our aim is to move from “managing degeneration” to preventing and repairing it.

Monthly updates • Global collaboration welcome • ORCID-verified identity

Core programs

We integrate stem cell biology, organoid engineering, exposure biology, and gene/cell therapy to design actionable interventions for joint repair and tissue regeneration.

Osteoarthritis & Joint Repair

Mechanics, inflammation, immune signaling, and regenerative strategies to rebuild joint stability and motion.

Environmental Exposure Biology

How pollution and toxicants accelerate degeneration; mapping stress and immune activation in joint tissue.

Stem Cells & Organoid Models

Human joint organoids that mimic cartilage/synovium to observe disease emergence and screen repair strategies.

Gene & Cell Therapy

Targeted delivery and cell-based repair to slow degeneration, control inflammation, and restore function.

Latest Highlight

Watching osteoarthritis form in vitro — and interrupting it

Stem-cell-derived joint organoids are exposed to real-world pollutants and controlled mechanical stress. We track degeneration in real time and evaluate regenerative gene/cell therapy strategies intended to repair cartilage rather than only treat pain.

News & Monthly Research Updates

Recent activity

Oct 2025 • Organoids

Pollution-accelerated cartilage breakdown modeled in vitro

Defined airborne mixtures induce inflammatory signatures linked to aggressive osteoarthritis—now a platform for anti-pollution regenerative testing.

Sep 2025 • Gene/Cell Therapy

Targeted cell therapy for joint surface repair

Concept to slow cartilage erosion and promote structural recovery in high-load regions.

Aug 2025 • Collaboration

Call for orthopedic & exposure biology partners

Seeking collaborators in early joint degeneration, exposure-driven inflammation, and regenerative delivery strategies.

Video / Outreach

Inside the lab

Briefings cover joint repair models, organoid platforms, and translational strategies for osteoarthritis and exposure-driven tissue damage.

Join & Collaborate

We collaborate globally

We share organoid disease models, exposure assays, and regenerative repair concepts. If you work on osteoarthritis, environmental toxicology, stem cell engineering, CRISPR, organoid modeling, or translational gene/cell therapy—let’s talk.